End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
125,000.00 KRW | +0.16% | +3.99% | +81.69% |
08-22 | South Korean Shares Rise After BOK Rate Hold; Yuhan Gains on FDA Approval | MT |
08-22 | Yuhan Shares Jump 4% After US FDA Approves Anti-Cancer Drug for US Markets | MT |
P/E ratio | Price to Book | PEG | EV / Sales | EV / EBITDA | EV / EBIT | Yield (Y) | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
62.44x | 4.505 | 6.06x | 4.51x | 53.15x | 83.99x | +0.33% | 7.1B | ||
24.24x | 2.511 | 4.08x | 3.71x | 13.11x | 20.31x | +1.38% | 80.55B | ||
25.27x | 2.026 | -1.75x | 2.85x | 12.06x | 15.38x | +1.78% | 12.14B | ||
114.59x | 22.66 | -0.36x | 15.22x | 83.23x | 100.46x | -.--% | 6.17B | ||
33.86x | 2.860 | 0.85x | 6.09x | 18.9x | 37.54x | +0.66% | 2.32B | ||
11.2x | 1.041 | 0.17x | - | - | - | +17.86% | 1.91B | ||
27.95x | 5.861 | 0.32x | - | - | - | - | 1.77B | ||
109.38x | - | 0.08x | - | - | - | - | 1.75B | ||
16.7x | 2.016 | 1.84x | - | - | - | +0.77% | 1.29B | ||
9.95x | -8.263600 | 0x | 1.04x | 3.67x | 4.04x | -.--% | 1.26B | ||
58.97x | 32.94 | -0.42x | 5.69x | 54.42x | -900.64x | -.--% | 1.09B | ||
12.72x | 0.6873 | 1.32x | - | - | - | +2.62% | 1.07B | ||
32.3x | 1.173 | 0.63x | 1.95x | 17.29x | 25.47x | - | 1.03B | ||
-40.56x | 4.196 | 0.15x | - | - | - | - | 909M | ||
Average | 35.64x | 5.71 | 0.93x | 5.13x | 31.98x | -76.68x | +2.54% | 8.6B | |
Weighted average by Cap. | 32.06x | 3.81 | 2.95x | 4.32x | 19.87x | 19.46x | +1.52% |
- Stock Market
- Equities
- A000100 Stock
- Sector Yuhan Corporation
- Sector valuations
MarketScreener is also available in this country: United States.
Switch edition